Our CTO, Dr. Cristian Ionescu-Zanetti, presented this webinar on Thursday, August 1. The webinar...
Participation will help advance liquid biopsy adoption by collaborating among key industry...
Glycocalyx research utilizing the BioFlux System
Publications demonstrate depth and breadth of Fluxion’s liquid biopsy technologies
FLUXION BIOSCIENCES RECEIVES NATIONAL CANCER INSTITUTE GRANT FOR DEVELOPMENT OF ERASE-SEQ LIQUID BIOPSY TECHNOLOGY
Grant will support advanced development and clinical validation with researchers at Cleveland Clinic
Custom panels can be now be validated and analyzed using ERASE-Seq variant caller